HEADER SUGAR BINDING PROTEIN 25-OCT-05 2ES3 TITLE CRYSTAL STRUCTURE OF THROMBOSPONDIN-1 N-TERMINAL DOMAIN IN P1 FORM AT TITLE 2 1.85A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBOSPONDIN-1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: THBS1, TSP, TSP1; SOURCE 6 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: DROSOPHILA S2 CELL; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: S2 CELL; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: EUKARYOTIC; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PMT-BIP-V5-HIS A KEYWDS THROMBOSPONDIN-1, TSP-1, TSPN, HBD, SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.TAN,J.WANG,J.LAWLER REVDAT 5 30-OCT-24 2ES3 1 REMARK REVDAT 4 23-AUG-23 2ES3 1 REMARK REVDAT 3 24-FEB-09 2ES3 1 VERSN REVDAT 2 19-FEB-08 2ES3 1 JRNL REVDAT 1 31-OCT-06 2ES3 0 JRNL AUTH K.TAN,M.DUQUETTE,J.H.LIU,K.SHANMUGASUNDARAM,A.JOACHIMIAK, JRNL AUTH 2 J.T.GALLAGHER,A.C.RIGBY,J.H.WANG,J.LAWLER JRNL TITL HEPARIN-INDUCED CIS- AND TRANS-DIMERIZATION MODES OF THE JRNL TITL 2 THROMBOSPONDIN-1 N-TERMINAL DOMAIN. JRNL REF J.BIOL.CHEM. V. 283 3932 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18065761 JRNL DOI 10.1074/JBC.M705203200 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.43 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 27640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1471 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1702 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.78 REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 106 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 257 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : 0.11000 REMARK 3 B33 (A**2) : -0.09000 REMARK 3 B12 (A**2) : -0.11000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.03000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.180 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.170 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.118 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.834 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3262 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4403 ; 1.814 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 415 ; 7.997 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 150 ;32.155 ;24.267 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 586 ;17.042 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;24.787 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 506 ; 0.152 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2446 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1538 ; 0.249 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2217 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 259 ; 0.184 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 77 ; 0.286 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 34 ; 0.207 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2125 ; 1.269 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3321 ; 2.008 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1251 ; 3.256 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1082 ; 5.207 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ES3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000035023. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07812 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29466 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.24000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.910 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB CODE: 1Z78 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG1500 AND 0.1M SODIUM ACETATE, REMARK 280 PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 7 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 24 O SER A 26 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O LYS A 24 O VAL B 12 1554 1.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 93 103.77 -175.28 REMARK 500 HIS A 94 73.54 -157.58 REMARK 500 GLU A 144 -123.57 51.05 REMARK 500 ASP A 152 -131.98 52.30 REMARK 500 GLN B 117 -138.43 60.99 REMARK 500 GLU B 144 -123.42 52.44 REMARK 500 ASP B 152 -137.44 54.42 REMARK 500 ASP B 172 8.33 58.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 93 HIS A 94 144.36 REMARK 500 HIS A 94 SER A 95 -138.60 REMARK 500 GLY A 133 GLN A 134 -138.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Z78 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE THROMBOSPONDIN-1 N-TERMINAL DOMAIN REMARK 900 RELATED ID: 1ZA4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE THROMBOSPONDIN-1 N-TERMINAL DOMAIN IN REMARK 900 COMPLEX WITH ARIXTRA REMARK 900 RELATED ID: 2ERF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE THROMBOSPONDIN-1 N-TERMINAL DOMAIN AT REMARK 900 1.45A RESOLUTION REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE OF THE WHOLE CONSTRUCT IS LISTED HERE: REMARK 999 RSPWNRIPESGGDNSVFDIFELTGAARKGSGRRLVKGPDPSSPAFRIEDA REMARK 999 NLIPPVPDDKFQDLVDAVRTEKGFLLLASLRQMKKTRGTLLALERKDHSG REMARK 999 QVFSVVSNGKAGTLDLSLTVQGKQHVVSVEEALLATGQWKSITLFVQEDR REMARK 999 AQLYIDCEKMENAELDVPIQSVFTRDLASIARLRIAKGGVNDNFQGVLQN REMARK 999 VRFVFGTTPEDILRNKGCSSSTSVLLTLDNNVVNGSSPAIRTNTGHHHHHH REMARK 999 THE PURIFIED PROTEIN WAS PROCESSED BY AN UNKNOWN REMARK 999 PROTEASE AFTER CONCENTRATION AND RE-PURIFIED BEFORE REMARK 999 CRYSTALLIZATION. THE EXACT N-TERMINAL OR C-TERMINAL REMARK 999 SEQUENCES ARE NOT KNOWN. THE SEQRES REPRESENTS THE REMARK 999 RESIDUES IN THE COORDINATES FOR CHAIN A. DBREF 2ES3 A 7 215 UNP P07996 TSP1_HUMAN 25 233 DBREF 2ES3 B 7 215 UNP P07996 TSP1_HUMAN 25 233 SEQRES 1 A 209 GLY GLY ASP ASN SER VAL PHE ASP ILE PHE GLU LEU THR SEQRES 2 A 209 GLY ALA ALA ARG LYS GLY SER GLY ARG ARG LEU VAL LYS SEQRES 3 A 209 GLY PRO ASP PRO SER SER PRO ALA PHE ARG ILE GLU ASP SEQRES 4 A 209 ALA ASN LEU ILE PRO PRO VAL PRO ASP ASP LYS PHE GLN SEQRES 5 A 209 ASP LEU VAL ASP ALA VAL ARG THR GLU LYS GLY PHE LEU SEQRES 6 A 209 LEU LEU ALA SER LEU ARG GLN MET LYS LYS THR ARG GLY SEQRES 7 A 209 THR LEU LEU ALA LEU GLU ARG LYS ASP HIS SER GLY GLN SEQRES 8 A 209 VAL PHE SER VAL VAL SER ASN GLY LYS ALA GLY THR LEU SEQRES 9 A 209 ASP LEU SER LEU THR VAL GLN GLY LYS GLN HIS VAL VAL SEQRES 10 A 209 SER VAL GLU GLU ALA LEU LEU ALA THR GLY GLN TRP LYS SEQRES 11 A 209 SER ILE THR LEU PHE VAL GLN GLU ASP ARG ALA GLN LEU SEQRES 12 A 209 TYR ILE ASP CYS GLU LYS MET GLU ASN ALA GLU LEU ASP SEQRES 13 A 209 VAL PRO ILE GLN SER VAL PHE THR ARG ASP LEU ALA SER SEQRES 14 A 209 ILE ALA ARG LEU ARG ILE ALA LYS GLY GLY VAL ASN ASP SEQRES 15 A 209 ASN PHE GLN GLY VAL LEU GLN ASN VAL ARG PHE VAL PHE SEQRES 16 A 209 GLY THR THR PRO GLU ASP ILE LEU ARG ASN LYS GLY CYS SEQRES 17 A 209 SER SEQRES 1 B 209 GLY GLY ASP ASN SER VAL PHE ASP ILE PHE GLU LEU THR SEQRES 2 B 209 GLY ALA ALA ARG LYS GLY SER GLY ARG ARG LEU VAL LYS SEQRES 3 B 209 GLY PRO ASP PRO SER SER PRO ALA PHE ARG ILE GLU ASP SEQRES 4 B 209 ALA ASN LEU ILE PRO PRO VAL PRO ASP ASP LYS PHE GLN SEQRES 5 B 209 ASP LEU VAL ASP ALA VAL ARG THR GLU LYS GLY PHE LEU SEQRES 6 B 209 LEU LEU ALA SER LEU ARG GLN MET LYS LYS THR ARG GLY SEQRES 7 B 209 THR LEU LEU ALA LEU GLU ARG LYS ASP HIS SER GLY GLN SEQRES 8 B 209 VAL PHE SER VAL VAL SER ASN GLY LYS ALA GLY THR LEU SEQRES 9 B 209 ASP LEU SER LEU THR VAL GLN GLY LYS GLN HIS VAL VAL SEQRES 10 B 209 SER VAL GLU GLU ALA LEU LEU ALA THR GLY GLN TRP LYS SEQRES 11 B 209 SER ILE THR LEU PHE VAL GLN GLU ASP ARG ALA GLN LEU SEQRES 12 B 209 TYR ILE ASP CYS GLU LYS MET GLU ASN ALA GLU LEU ASP SEQRES 13 B 209 VAL PRO ILE GLN SER VAL PHE THR ARG ASP LEU ALA SER SEQRES 14 B 209 ILE ALA ARG LEU ARG ILE ALA LYS GLY GLY VAL ASN ASP SEQRES 15 B 209 ASN PHE GLN GLY VAL LEU GLN ASN VAL ARG PHE VAL PHE SEQRES 16 B 209 GLY THR THR PRO GLU ASP ILE LEU ARG ASN LYS GLY CYS SEQRES 17 B 209 SER FORMUL 3 HOH *257(H2 O) HELIX 1 1 ILE A 15 GLY A 20 1 6 HELIX 2 2 GLY A 20 GLY A 25 1 6 HELIX 3 3 ASP A 45 ILE A 49 5 5 HELIX 4 4 PRO A 53 LYS A 68 1 16 HELIX 5 5 PRO A 164 VAL A 168 5 5 HELIX 6 6 ASP A 172 ILE A 176 1 5 HELIX 7 7 THR A 204 LYS A 212 1 9 HELIX 8 8 ILE B 15 GLY B 20 1 6 HELIX 9 9 ASP B 45 ILE B 49 5 5 HELIX 10 10 PRO B 53 LYS B 68 1 16 HELIX 11 11 PRO B 164 PHE B 169 5 6 HELIX 12 12 ASP B 172 SER B 175 5 4 HELIX 13 13 THR B 204 ASN B 211 1 8 SHEET 1 A 4 VAL A 12 ASP A 14 0 SHEET 2 A 4 GLY A 192 VAL A 200 -1 O PHE A 199 N PHE A 13 SHEET 3 A 4 ALA A 40 ILE A 43 -1 N PHE A 41 O LEU A 194 SHEET 4 A 4 ARG A 28 VAL A 31 -1 N ARG A 29 O ARG A 42 SHEET 1 B 6 VAL A 12 ASP A 14 0 SHEET 2 B 6 GLY A 192 VAL A 200 -1 O PHE A 199 N PHE A 13 SHEET 3 B 6 GLY A 69 GLN A 78 -1 N LEU A 73 O ARG A 198 SHEET 4 B 6 TRP A 135 GLN A 143 -1 O ILE A 138 N ALA A 74 SHEET 5 B 6 ARG A 146 ILE A 151 -1 O GLN A 148 N PHE A 141 SHEET 6 B 6 LYS A 155 GLU A 160 -1 O GLU A 157 N LEU A 149 SHEET 1 C 5 LYS A 119 VAL A 125 0 SHEET 2 C 5 THR A 109 VAL A 116 -1 N LEU A 114 O HIS A 121 SHEET 3 C 5 GLN A 97 ASN A 104 -1 N VAL A 102 O ASP A 111 SHEET 4 C 5 ARG A 83 ARG A 91 -1 N GLY A 84 O SER A 103 SHEET 5 C 5 ALA A 177 ILE A 181 -1 O ARG A 180 N ALA A 88 SHEET 1 D 4 VAL B 12 ASP B 14 0 SHEET 2 D 4 GLY B 192 VAL B 200 -1 O PHE B 199 N PHE B 13 SHEET 3 D 4 ALA B 40 ILE B 43 -1 N PHE B 41 O LEU B 194 SHEET 4 D 4 ARG B 28 VAL B 31 -1 N ARG B 29 O ARG B 42 SHEET 1 E 6 VAL B 12 ASP B 14 0 SHEET 2 E 6 GLY B 192 VAL B 200 -1 O PHE B 199 N PHE B 13 SHEET 3 E 6 GLY B 69 GLN B 78 -1 N LEU B 71 O VAL B 200 SHEET 4 E 6 TRP B 135 GLN B 143 -1 O LEU B 140 N LEU B 72 SHEET 5 E 6 ARG B 146 ILE B 151 -1 O GLN B 148 N PHE B 141 SHEET 6 E 6 LYS B 155 GLU B 160 -1 O GLU B 157 N LEU B 149 SHEET 1 F 5 LYS B 119 VAL B 125 0 SHEET 2 F 5 THR B 109 VAL B 116 -1 N LEU B 114 O HIS B 121 SHEET 3 F 5 GLN B 97 ASN B 104 -1 N VAL B 102 O ASP B 111 SHEET 4 F 5 ARG B 83 ARG B 91 -1 N LEU B 86 O VAL B 101 SHEET 5 F 5 ALA B 177 ILE B 181 -1 O ARG B 180 N ALA B 88 SSBOND 1 CYS A 153 CYS A 214 1555 1555 2.03 SSBOND 2 CYS B 153 CYS B 214 1555 1555 2.03 CRYST1 40.024 41.709 59.986 73.63 89.59 75.73 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024985 -0.006353 0.001731 0.00000 SCALE2 0.000000 0.024739 -0.007467 0.00000 SCALE3 0.000000 0.000000 0.017414 0.00000